RCKT (NASDAQ) Rule 144: Director sales listed; 3,361 vested shares

Rhea-AI Filing Summary

RCKT submitted a Rule 144 notice disclosing 3,361 shares of Common Stock tied to a restricted stock vesting event dated 05/11/2026.

The filing also lists prior sales by Martin Wilson of 12,253 shares on 02/13/2026 for $40,583.16 and 1,376 shares on 02/18/2026 for $4,593.78.

Insights

Compliance Analyst

Rule 144 notice records a vesting-driven resale filing and small prior dispositions.

The filing lists 3,361 shares to be sold following a restricted stock vesting on 05/11/2026. This is presented as a routine transfer tied to compensation rather than an open-market solicitation.

Prior dispositions by Martin Wilson total 13,629 shares across two dates in February 2026 with aggregate proceeds shown. Timing and sale mechanics beyond the dates are not detailed in the excerpt.

Key Figures

Shares to be sold: 3,361 shares Prior sale: 12,253 shares Prior sale: 1,376 shares

3 metrics

Shares to be sold 3,361 shares Restricted stock vesting on 05/11/2026

Prior sale 12,253 shares Sale on 02/13/2026 for $40,583.16

Prior sale 1,376 shares Sale on 02/18/2026 for $4,593.78

Key Terms

Rule 144, Restricted Stock Vesting, Securities To Be Sold

3 terms

Rule 144 regulatory

"144: Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Securities To Be Sold | 05/11/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

What does RCKT's Rule 144 filing disclose?

The filing discloses 3,361 shares of Common Stock from a restricted stock vesting on 05/11/2026. It also lists prior sales by Martin Wilson in February 2026 totaling 13,629 shares with stated proceeds.

Who sold shares recently according to the RCKT filing?

The filing shows transactions by Martin Wilson: 12,253 shares on 02/13/2026 for $40,583.16 and 1,376 shares on 02/18/2026 for $4,593.78. These are recorded as prior dispositions.

Why are 3,361 shares listed for sale in the RCKT filing?

Those 3,361 shares are tied to a restricted stock vesting event dated 05/11/2026 and are shown under the filing's "Securities To Be Sold" section as compensation-related shares becoming available.

Does the filing state how the shares will be sold?

The excerpt lists the shares and dates but does not specify sale mechanics or distribution methods. It identifies the 3,361 shares as resulting from restricted stock vesting on 05/11/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 03:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001704342
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Wilson Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3361	12118.42	109193549	05/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/11/2026	Restricted Stock Vesting	Issuer			3361	05/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	02/13/2026	12253	40583.16
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	02/18/2026	1376	4593.78

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	05/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Wilson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)